ALL libraries (COBIB.SI union bibliographic/catalogue database)
-
The role of proteasome, immunoproteasome and autophagy in the therapy of chronic lymphocytic leukemia = Vloga proteasoma, imunoproteasoma in avtofagije v terapiji kronične limfocitne levkemije : doctoral dissertationAvsec, Damjan, farmacevt, 1993-Chronic lymphocytic leukemia (CLL) is a disease of accumulating malignant mature-appearing monoclonal B-lymphocytes in blood, bone marrow, and lymphatic tissues. The incidence of CLL in Slovenia is ... among the Europe’s highest, and with current demographic changes the burden of the disease is expected to increase in the future. In the last decade, a series of small, targeted molecules made it from bench-to-bedside in CLL. Despite the remarkable clinical success of BCR pathway inhibitors (ibrutinib, acalabrutinib, idelalisib, and duvelisib) and Bcl-2 antagonist (venetoclax), we are now faced with concerning drawbacks of these therapies, including high rates of discontinuation, severe adverse events, and the inevitable emergence of resistance. The primary purpose of our work was to address the unmet clinical need to improve the treatment of patients with CLL by delineating the role of proteasome (cP), immunoproteasome (iP), and autophagy in the therapy of CLL. We discovered that different cP/iP inhibitors suppress the prosurvival NF?B signaling and trigger apoptotic cell death independently of genetic background also in hard-to-treat patient-derived CLL cells carrying prognostically unfavorable del(11q), del(17p) and unmutated IGHV. These inhibitors (n=11) are selectively cytotoxic toward malignant CLL cells in low nanomolar concentrations, with cP inhibitor carfilzomib (EC50, 48h 2 nM) and iP inhibitor ONX-0914 (EC50, 48h 10 nM) being investigated in detail. They synergized with targeted therapies by perturbing the prosurvival BCR and NF?B pathways, thus culminating in a synergistic promotion of apoptosis. Moreover, they demonstrated a remarkable resistance-overcoming activity in both de-novo established resistant CLL clones and ex-vivo identified targeted therapy insensitive patient-derived CLL cells. We identified the molecular background to venetoclax resistance in CLL, including IFN?-mediated cytoprotection and iP formation, along with altered apoptotic pathways (downregulation of Bak and Bax, increased p-Bcl-2). The use of ONX-0914 successfully tackled IFN?-mediated cytoprotection and eradicated resistance in venetoclax resistant CLL clone. Delineating the role of autophagy in CLL, we found that targeted therapies activate autophagy via BTK/Akt, AMPK/ULK1/Beclin-1 and PI3K/Akt pathways. Block on autophagy at AMPK (dorsomorphin, EC50, 48h 4.6 µM), ULK1/2 (MRT68921, EC50, 48h 2.1 µM), VPS34 (VPS34-IN1, EC50, 48h 7.9 µM), and autolysosome formation (chloroquine, EC50, 48h 13.6 µM) induced apoptosis independently of the genetic background in hard-to-treat CLL cells carrying prognostically unfavorable del(11q), del(17p), and unmutated IGHV. Activation of autophagy was not cytotoxic to CLL cells, thus establishing that autophagy has a prosurvival role in CLL. De-novo established targeted therapy resistant CLL clones overexpressed several autophagic proteins. Autophagy inhibitors overcame this resistance and synergized with targeted therapies against hard-to-treat CLL cells. Several autophagy proteins were overexpressed in CLL cells compared to healthy controls, which defined the selective cytotoxicity of autophagy inhibitors against CLL cells. The levels of p62/SQSTM1 were higher in patients with unmutated IGHV, thus linking the p62/SQSTM1 to an adverse prognosis. In conclusion, we elucidated the role of cP, iP, and autophagy in the therapy of CLL and put forth a solid rationale to consider the use of cP, iP, and autophagy inhibitors for the treatment of relapsed/refractory patients with CLL.Type of material - dissertation ; adult, seriousPublication and manufacture - Ljubljana : [D. Avsec], 2023Language - english, slovenianCOBISS.SI-ID - 167069187
Author
Avsec, Damjan, farmacevt, 1993-
Other authors
Mlinarič-Raščan, Irena |
Podgornik, Helena
Topics
Kronična limfocitna levkemija |
Tarčna zdravila |
KLL |
proteasom |
immunoproteasom |
avtofagija |
tarčna zdravila |
odpornost |
ibrutinib |
idelalizib |
venetoklaks |
NFκB |
B-celični receptor
Library/institution |
City | Acronym | For loan | Other holdings |
---|---|---|---|---|
Faculty of Pharmacy, Ljubljana | Ljubljana | FFALJ |
reading room 1 cop.
|
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Avsec, Damjan, farmacevt, 1993- | 52092 |
Mlinarič-Raščan, Irena | 12443 |
Podgornik, Helena | 12684 |
Source: Personal bibliographies
and: SICRIS
Select pickup location:
Material pickup by post
Delivery address:
Address is missing from the member's data.
The address retrieval service is currently unavailable, please try again.
By clicking the "OK" button, you will confirm the pickup location selected above and complete the reservation process.
By clicking the "OK" button, you will confirm the above pickup location and delivery address, and complete the reservation process.
By clicking the "OK" button, you will confirm the address selected above and complete the reservation process.
Notification
Automatic login and reservation service currently not available. You can reserve the material on the Biblos portal or try again here later.
Subject headings in COBISS General List of Subject Headings
Select pickup location
The material from the parent unit is free. If the material is delivered to the pickup location from another unit, the library may charge you for this service.
Pickup location | Material status | Reservation |
---|
Reservation in progress
Please wait a moment.
Reservation was successful.
Reservation failed.
Reservation...
Membership card:
Pickup location: